Matthias B Moor Selected Research

tetrahydroaldosterone

6/2022

Urinary tetrahydroaldosterone is associated with circulating FGF23 in kidney stone formers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias B Moor Research Topics

Disease

2	Kidney Calculi (Kidney Stone) 06/2022 - 01/2022
2	COVID-19 01/2022 - 11/2021
2	Neoplasms (Cancer) 11/2021 - 01/2016
1	Infections 01/2022
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 11/2021
1	Premature Aging 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 12/2015

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 01/2022 - 11/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 11/2021
1	tetrahydroaldosteroneIBA 06/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	calcium phosphateIBA 01/2022
1	empagliflozinIBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022
1	CalciumIBA 01/2022
1	Calcium OxalateIBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	ocrelizumabIBA 11/2021
1	Rituximab (Mabthera)FDA Link 11/2021
1	InterferonsIBA 11/2021
1	MineralsIBA 01/2020
1	CateninsIBA 12/2015

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2016
1	Transplantation 11/2021